Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 68.12% is 146% above its 5-year average of -148.73%, near the high end of its 5-year range (-517.43%–78.77%).
As of the fiscal period ended Tuesday, June 30, 2026. 153.89% above its 12-month average of 26.83%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 68.12%.
RETURN ON EQUITY (ROE)
68.12%
RETURN ON EQUITY (ROE) AVG TTM
26.83%
RETURN ON EQUITY (ROE) AVG 3Y
-169.45%
RETURN ON EQUITY (ROE) AVG 5Y
-148.73%
RETURN ON EQUITY (ROE) AVG 10Y
-127.12%
RETURN ON EQUITY (ROE) AVG 15Y
-111.36%
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+153.89%
CURRENT VS 3Y AVG
+140.20%
CURRENT VS 5Y AVG
+145.80%
CURRENT VS 10Y AVG
+153.59%
CURRENT VS 15Y AVG
+161.17%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-40.76%
median of 689 covered companies
CURRENT VS SECTOR MEDIAN
+267.13%
vs the sector median at left
Fortress Biotech, Inc.
Market Cap
$139.73M
Return on Equity (ROE)
68.12%
TTM Avg
26.83%
3Y Avg
-169.45%
5Y Avg
-148.73%
Market Cap
$139.08M
Return on Equity (ROE)
-44.26%
TTM Avg
-34.18%
3Y Avg
285.39%
5Y Avg
-5868.11%
Market Cap
$137.57M
Return on Equity (ROE)
-10.08%
TTM Avg
-25.77%
3Y Avg
-36.68%
5Y Avg
-27.09%
Market Cap
$141.94M
Return on Equity (ROE)
-30.03%
TTM Avg
-86.56%
3Y Avg
-69.53%
5Y Avg
-37.30%
Market Cap
$142.47M
Return on Equity (ROE)
N/A
TTM Avg
-182.86%
3Y Avg
-123.00%
5Y Avg
-90.58%
Market Cap
$143.18M
Return on Equity (ROE)
-120.33%
TTM Avg
-117.87%
3Y Avg
-76.44%
5Y Avg
-55.77%
Market Cap
$135.99M
Return on Equity (ROE)
-43.42%
TTM Avg
-36.99%
3Y Avg
-36.99%
5Y Avg
-36.99%
Market Cap
$143.60M
Return on Equity (ROE)
-43.40%
TTM Avg
-27.96%
3Y Avg
-44.92%
5Y Avg
-37.65%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Fortress Biotech, Inc. (FBIOP) | $139.73M | 68.12% | 26.83% | -169.45% | -148.73% |
| Alpha Cognition Inc (ACOG)vs › | $139.08M | -44.26% | -34.18% | 285.39% | -5868.11% |
| KORU Medical Systems, Inc. (KRMD)vs › | $137.57M | -10.08% | -25.77% | -36.68% | -27.09% |
| Immuneering Corporation (IMRX)vs › | $141.94M | -30.03% | -86.56% | -69.53% | -37.30% |
| Sutro Biopharma, Inc. (STRO)vs › | $142.47M | N/A | -182.86% | -123.00% | -90.58% |
| Nyxoah S.A. (NYXH)vs › | $143.18M | -120.33% | -117.87% | -76.44% | -55.77% |
| Atrium Therapeutics, Inc. (RNA)vs › | $135.99M | -43.42% | -36.99% | -36.99% | -36.99% |
| Protara Therapeutics, Inc. (TARA)vs › | $143.60M | -43.40% | -27.96% | -44.92% | -37.65% |
| Freenome, Inc. (FRNM)vs › | $135.31M | N/A | N/A | N/A | N/A |
| Korsana Biosciences, Inc. (KRSA)vs › | $144.23M | -131.85% | -36.69% | -135.43% | -129.92% |
ROE
68.1%
ROA
35.3%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 68.12% |
| 2026-03-31 | 78.77% |
| 2025-12-31 | 13.66% |
| 2025-09-30 | 7.14% |
| 2025-06-30 | -33.54% |
| 2025-03-31 | -185.01% |
| 2024-12-31 | -202.30% |
| 2024-09-30 | -229.28% |
| 2024-06-30 | -227.61% |
| 2024-03-31 | -236.77% |
| 2023-12-31 | -268.97% |
| 2023-09-30 | -469.63% |
| 2023-06-30 | -517.43% |
| 2023-03-31 | -244.34% |
| 2022-12-31 | -207.51% |
| 2022-09-30 | -147.87% |
| 2022-06-30 | -115.85% |
| 2022-03-31 | -73.21% |
| 2021-12-31 | -59.54% |
| 2021-09-30 | -41.48% |
| 2021-06-30 | -30.66% |
| 2021-03-31 | -40.58% |
| 2020-12-31 | -46.37% |
| 2020-09-30 | -58.41% |
| 2020-06-30 | -89.19% |
| 2020-03-31 | -144.31% |
| 2019-12-31 | -152.43% |
| 2019-09-30 | -191.31% |
| 2019-06-30 | -166.98% |
| 2019-03-31 | -296.57% |
| 2018-09-30 | -184.47% |
| 2018-06-30 | -182.46% |
| 2018-03-31 | -182.26% |
| 2017-12-31 | -127.21% |
| 2017-09-30 | -200.02% |
| 2017-06-30 | -82.69% |
| 2017-03-31 | -114.92% |
| 2016-12-31 | -143.12% |
| 2016-09-30 | -135.70% |
| 2016-06-30 | -155.30% |
| 2016-03-31 | -109.00% |
| 2015-12-31 | -85.19% |
| 2015-09-30 | -74.81% |
| 2015-06-30 | -47.49% |
| 2015-03-31 | -41.68% |
| 2014-12-31 | -28.91% |
| 2014-09-30 | -38.22% |
| 2014-06-30 | -41.06% |
| 2014-03-31 | -47.25% |
| 2013-12-31 | -45.72% |
| 2013-09-30 | -41.16% |
| 2013-06-30 | -70.28% |
| 2013-03-31 | -111.91% |
| 2012-12-31 | -125.31% |
| 2012-09-30 | -88.11% |
| 2012-06-30 | -68.29% |
| 2012-03-31 | -151.47% |
| 2011-12-31 | -190.05% |
